Abstract
Study Objectives To determine the prevalence of obstructive sleep apnea (OSA) in adults with Down syndrome (DS), to investigate factors related to OSA severity and to identify which sleep questionnaire is the most appropriate for the screening of OSA in this population.
Methods Cross-sectional study that consecutively included 60 adults with DS. All patients underwent type III polysomnography and clinical and laboratory data were collected; sleep assessment questionnaires were applied. Multiple linear regression models evaluated the associations between OSA severity (measured by the respiratory event index - REI) and clinical and laboratory data and sleep questionnaires (Epworth Sleepiness Scale, Pittsburgh Sleep Quality Index, BERLIN and STOP-Bang questionnaires).
Results Results show that 60 (100%) adults with DS had OSA, with moderate-severe OSA identified in 49 (81.6%). At the multivariate linear regression, REI significantly correlated with hematocrit levels, BMI and STOP-Bang questionnaire (SBQ) results (P <0.001). The positive STOP-Bang ≥3 points) showed 100% of sensitivity (95%CI: 92.75-100%), 45.45% of specificity (95%CI: 16.75-76.62), positive predictive value of 89.09% (95%CI: 82.64-93.34%), negative predictive value of 100%, accuracy of 90% (95%CI: 79.49-96.24%) and OR of 24.29.
Conclusions Adults with DS have a very high prevalence of OSA. Hematocrit levels, BMI and SBQ showed a strong correlation with OSA severity. The SBQ performed well in identifying moderate to severe OSA in this population. Considered together, these results point to the need to perform OSA screening in all adults with DS, and STOP-Bang may play a role in this screening.
Introduction
Down syndrome (DS) is the most prevalent chromosomal abnormality, with approximately 5.4 million affected individuals worldwide[1], with 206,000 of these patients in the United States[2]. In the last decades, the life expectancy of individuals with DS has considerably increased and currently exceeds 60 years in developed countries.[1] A common comorbidity in adults with DS is obstructive sleep apnea (OSA), of which prevalence ranges from 78-100% in these individuals.[3-8] Moreover, when compared to the general population, the OSA is more often classified as severe and is associated with more significant hypoxemia in individuals with DS.[3] In turn, OSA-related hypoxemia has been associated with decreased verbal IQ, executive function, visual-perceptual skills and increase in mood disorders in patients with DS.[9]
The higher prevalence and severity of OSA in patients with DS is related to the phenotypic characteristics of DS itself. These changes include upper airway hypotonia, midface hypoplasia, mandibular hypoplasia, glossoptosis, lingual tonsil hypertrophy, pharyngomalacia, laryngomalacia, and tonsil / adenoid hypertrophy. Additionally, factors such as obesity and hypothyroidism, which are also frequently observed in individuals with DS, favor OSA onset.[3,9,10]
Despite the high risk for OSA in individuals with DS, recommendations for OSA screening and polysomnography in this population are not well established. The American Academy of Pediatrics recommends that polysomnography be performed in all children with DS up to the age of 4, or earlier, if OSA symptoms are present.[11] As for adult patients with DS, the recommendation is also to perform OSA screening, but it is not clearly defined how the screening should be performed (e.g., using a questionnaire or through polysomnography), nor the periodicity of this screening (e.g., annual or biannual assessment). Another important issue is that, for the adult population with DS, there are no validated questionnaires for OSA screening and there is no specific recommendation on which questionnaire should be applied to this special group of patients.
Considering that in the overall population, adequate OSA treatment helps to reduce the incidence of comorbidities and improve neurocognitive functions[12], the identification of OSA in patients with DS is essential to ensure a better neurological prognosis.
Therefore, the aim of the present study was to evaluate OSA prevalence and factors associated with OSA severity in adult patients with DS. Moreover, we investigated which questionnaire is the most appropriate for OSA screening in this population.
Methods and materials
This study was carried out from October 2017 to October 2018 and included 66 adults with DS attending the Down Syndrome Reference Center (CRISDOWN) of Hospital Regional da Asa Norte (HRAN) linked to Faculdade de Medicina da Escola Superior de Ciências da Saúde (ESCS), Brasília, Federal District, Brazil.
Subjects were sequentially recruited and submitted to type III polysomnography, anthropometric data collection, laboratory tests and sleep assessment questionnaires.
The inclusion criteria comprised individuals with DS treated at our service, of both genders, good overall health status, aged 18 years and older, capable to understand and accept the study and its procedures. The following were excluded: (1) individuals under 18 years of age; (2) patients undergoing treatment for sleep disorders; (3) patients with a history of conditions that could affect brain structure or function (such as cerebrovascular accident or head trauma); (4) those who refused to participate in the study.
A researcher explained the study in details to all participants with DS and their proxies. Those who agreed to participate in the study signed the free and informed written consent form. The study was approved by the Research Ethics Committee of Fundação de Ensino e Pesquisa em Ciências da Saúde (FEPECS) according to Opinion number 1,656,332/2016 and followed the principles established by the Declaration of Helsinki.
Data Collection and Research protocol
After the study participants were defined, a structured interview was carried out to collect the following data: age, gender, BMI, neck circumference (NC), Mallampati class and comorbidities. Venous blood samples were obtained for analysis after a fasting period of 12 to 15 hours. Laboratory tests included complete blood count, thyroid stimulating hormone (TSH), fasting glucose, HOMA-IR, alanine aminotransferase (ALT), uric acid, urea, creatinine and sodium levels.
The following questionnaires were also applied for sleep assessment: Epworth Sleepiness Scale (ESS)[13,14], Pittsburgh Sleep Quality Index (PSQI)[15], BERLIN Questionnaire (BQ)[16,17], and the STOP-Bang Questionnaire (SBQ)[18,19].
In the sleep assessment questionnaires, due to the absence of cutoff points specifically defined for the adult population with DS, the ones defined for the overall population were used, as follows: (1) probable presence of excessive daytime sleepiness in the ESS (total score> 10)[13]; (2) poor sleep quality in the PSQI (total score >5)[15]; (3) risk for OSA in the BQ (two or more positive categories)[17]; (4) risk for OSA in the SBQ (3 or more affirmative answers)[18]. These questionnaires were answered by the patients’ proxies, in agreement with other studies in individuals with DS.[4,5,20]
Moreover, all research subjects underwent type III polysomnography according to international guidelines.[21] This type III polysomnography has been previously used in OSA studies in individuals with DS[22] and in other populations[23,24].
In the present study, the equipment used to perform the type III PSG assessments was the ApneaLink Air (ResMed Germany Inc.), which has been previously used in other important studies.[23,24] This equipment allowed monitoring with the use of nasal pressure cannula (for airflow and snore detection), chest piezoelectric strap (for respiratory effort detection) and pulse oximetry (to monitor peripheral arterial oxygen saturation - SpO2 and heart rate).
The total recording time was used as the denominator to calculate the respiratory event index (REI).[21,25] The PSG was assembled by a specialized technician from the Sleep Laboratory of our service. The patient was then referred to a temperature-controlled and quiet bedroom, to undergo the all-night test, without the technician’s supervision. All patients were accompanied by a proxy during the examination, who slept in a separate bed, but in the same room. Recording of sleep examination records started at 8pm and stopped at 7am in the following morning.
The respiratory events were defined as follows: (1) hypopnea, when there was a ≥30% reduction in airflow for at least 10 seconds, observed through the nasal cannula, associated with a decrease in SpO2 of at least 3%; (2) obstructive apnea, due to the absence or reduction ≥ 90% of airflow for at least 10 seconds in the presence of respiratory effort; (3) mixed apnea, due to the absence or reduction ≥ 90% of airflow, without the presence of respiratory effort only at the beginning of the event; (4) central apnea, due to absence or ≥ 90% reduction in airflow for at least 10 seconds associated with absence of respiratory effort throughout the event.[26]
The OSA was then classified as mild, moderate or severe. It was classified as mild OSA when the REI was between 5 and 14.9 events / hour, moderate when the REI was between 15 and 29.9 events / hour and severe when the REI was 30 or more events / hour (detected by type III polysomnography).[26]
The polysomnography exams were manually reviewed by a single physician according to AASM standardized criteria.[26] The examiner was blinded to any patient clinical data. The PSG examinations were considered valid when there was ≥ 4 hours of adequate recording without significant loss of sensor signal (nasal pressure cannula, pulse oximetry and chest strap).[27-29]
Statistical Analysis
Numerical data are presented as mean and standard deviation. Categorical data are presented as absolute numbers and percentage. The statistical analysis was initially performed with simple (univariate) linear regression analysis to identify factors correlated with REI. Subsequently, variables with p-values <0.15 were considered for the multiple linear regression analysis, using variable selection according to the backward technique. A p-value <0.05 was used as the criterion for the retention of variables in the final multiple linear regression model.[30,31] Logarithmic transformation was used to obtain the dependent variable distribution normalization. Assumptions of normality, homocedascity (constant variance) and residual independence were assessed. The presence of multicollinearity was assessed by estimating the variance inflation factor (VIF), with VIF >5 being used as an indication of multicollinearity in the multiple linear regression analysis.[31]
The adjusted coefficient of determination R2 was used as a measure of fit quality. Normality was assessed by visual inspection of histograms and by applying the Shapiro-Wilk normality test.[32,33]
The sleep questionnaires that remained in the final multiple linear regression analysis model were used as categorical variable (positive or negative questionnaire) together with moderate to severe OSA (present or absent) in 2x2 contingency tables. Consequently, odds ratio (OR), sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy were calculated.
The R software (R Foundation, Vienna, Austria) was used for statistical data analysis.[32,33] All hypothesis tests were bilateral. Values of p <0.05 were considered significant.
Results
During the study period, 66 adults with DS were included in the research. Of this total, 60 completed and 06 patients (9%) dropped out of the study out of their own will. Ten percent (6 subjects) had to undergo the PSG again due to technical problems, such as loss of signal from one of the sensors.
Table 1 shows the participants’ demographic characteristics (N = 60). A total of 33 men (55%) and 27 women (45%) participated in the study and the mean age of the sample was 27.7 ± 9.1 years. Obesity and overweight were observed in 27 (45%) and 14 (23%) subjects, respectively. Oropharyngeal examination showed that 52 (86%) participants were Mallampati class III or IV. Clinically, 30 individuals (50%) were diagnosed with congenital heart disease, and 7 had undergone previous surgical correction.
Clinical and laboratory characteristics of adult participants with Down syndrome.
Regarding the questionnaires used for sleep assessment (Table 2) it was observed that: (1) ESS suggested sleepiness (ESS >10) in 32 participants (53%); (2) PSQI identified sleep disorders (PSQI >5) in 37 participants (61%); (3) the BQ and (4) the SBQ indicated high risk of OSA in 49 participants (81%) and 55 participants (91%), respectively.
Sleep-related characteristics of adult participants with Down syndrome.
When performing the type III PSG, it was observed that the 60 (100%) study individuals had OSA (REI ≥ 5 events / h), with moderate to severe OSA in 49 (81.6%). Central sleep apnea syndrome (> 5 events / h) was not observed in any of the subjects. At the simple linear regression analysis (Table 3), several variables showed a significant linear association with the dependent variable (REI), such as uric acid, glucose, hematocrit, HOMA-IR, BMI, ALT, neck circumference, Mallampati class, BQ, ESS, PSQI and SBQ. However, the multiple linear regression analysis (final model), as shown in Table 4, identified only hematocrit, BMI and SBQ as independent predictors of REI. On average, for every 1-unit increase in the hematocrit or BMI variables, and for SBQ to go from negative to positive, the REI response variable increased by 0.073, 0.028, and 0.616 respectively. None of the other sleep questionnaire scores (BQ, ESS, and PSQI) demonstrated a significant positive linear association with REI.
Results of simple (univariate) linear regression analysis for the dependent variable respiratory event index.
Results of the multivariate linear regression analysis for the dependent variable respiratory event index.
As the SBQ remained in the final multiple linear regression model, the contingency table analysis (2x2) with moderate to severe OSA was performed. Positive SBQ (3 or more affirmative answers) showed 100% of sensitivity (95%CI: 92.75-100%), 45.45% of specificity (95%CI: 16.75-76.62%), 89.09% of PPV (95%CI: 82.64-93.34%), 100% of NPV, 90% of accuracy (95%CI: 79.49-96.24%) and OR of 24.29.
Discussion
The present study contributes with important findings. First, when compared to previously published studies[3-8], it included the largest number of adults with DS. Second, it evaluated for the first time the role of the SBQ in OSA screening in this population. Moreover, this was the first study to evaluate the prevalence of OSA in adults with DS in Brazil.
Thus, we demonstrated that the prevalence of OSA in individuals with DS in our sample was 100%. Moreover, 81.6% of the subjects had moderate to severe OSA. Interestingly, participants with DS were included in the present study regardless of whether or not they had significant complaints of sleep-disordered breathing. This fact supports the idea of performing active OSA screening in all adult individuals with DS[3,5] during routine consultations. Compared to other OSA studies in adult individuals with DS, the prevalence of OSA was also high and ranged from 78 to 100%. It is noteworthy that the number of individuals included in such studies was usually small, the smallest with 3 patients and the largest with 47 individuals[3-8].
The difference in OSA prevalence between studies possibly derives from heterogeneities between them, such as different types of polysomnography for OSA diagnosis, as well as sample characterization and size.
Our results also demonstrated that BMI is positively correlated with OSA severity indicated by the REI. This correlation corroborates the high prevalence of the observed moderate to severe OSA, based on the fact that 68% of our adult patients with DS were obese or overweight. This correlation between BMI and REI has been well documented in the overall population[34] and in adults with DS[3,5,6].
Interestingly, the hematocrit level is also correlated with OSA severity. This correlation has been previously identified in individuals in the overall population with OSA[35,36]; however, this finding had not yet been demonstrated in the population of adult individuals with DS. This correlation possibly reflects the presence and greater severity of nocturnal hypoxemia that stimulates increased erythropoietin synthesis, with consequent elevated erythrocyte production and increased hematocrit levels[35,36].
Regarding the use of questionnaires for OSA screening, our study was the first to identify a questionnaire capable of playing a significant role in OSA screening in adults with DS. The sensitivity and accuracy of the SBQ for detecting moderate to severe OSA was 100% and 90%, respectively.
This result indicates that the SBQ should be applied to all adult individuals with DS, thus helping to prioritize individuals who need to undergo the polysomnography. This recommendation becomes important as we observe that the international guidelines indicate OSA screening in adults with DS, but do not clearly indicate how this screening should be performed[37-39].
Finally, regarding the results of the BQ, ESS and PSQI questionnaires not showing a role in relation to OSA in our study, that is in accordance with the results of the study by Giménez et al[5].
Our study shows some limitations. First, the individuals were submitted to a type III PSG and not to a full PSG test. Consequently, we did not have information related to sleep architecture, and OSA severity (REI) may have been underestimated. However, the type III PSG has been used in DS with good results.[22,40-42] Moreover, the number of technical problems that required the type III PSG to be repeated was small (10% in our study), which is in accordance to previous studies in DS or not (3– 18%).[21,22,43-45] The present study was performed in a single center for DS patients from a reference hospital. Therefore, it is possible that our results may represent a specific population of adults with DS, since DS patients treated in a community care institution were not included.
Conclusion
In conclusion, our study confirmed the very high prevalence of OSA in adults with DS. Additionally, the SBQ, hematocrit levels and BMI showed a strong correlation with OSA severity. Furthermore, the SBQ showed high sensitivity and specificity in identifying moderate to severe OSA in this population. Taken together, these results indicate the need for OSA screening in all adults with DS. Nevertheless, considering the limited access to polysomnography for all patients, the use of hematocrit levels and BMI, and especially the application of the SBQ can select the individuals at higher risk for OSA who should undergo the polysomnography. However, further studies with a larger population of patients with DS are needed for more definitive conclusions to be drawn.
Data Availability
All files used to write the manuscript are available in a public database repository.
Acknowledgement
The authors would like to thank the study participants and their proxies for their patience and contributions to the research.
Footnotes
Conflicts of Interest The authors declare that they have viewed and approved the manuscript and that the opinions expressed in the submitted article are theirs and not an official position of the institution or the funder. This study was not supported by the industry. The other authors have no conflicts of interest to declare.
Sources of Funding The study received financial support through process number 064.000.560/2015 of Public Notice number 40 of 10/29/2015, published in DODF n. 213, of 11/06/2015, regarding the Homologation of the Final Selection Result of Research Projects to be funded by Fundação de Ensino e Pesquisa em Ciências da Saúde (FEPECS).
References
